Find Out if the Oncotype DX Test Can Help Personalize Your Treatment

The Oncotype DX tests are genomic tests that may help guide treatment decisions for patients with early-stage breast cancer: non-invasive breast cancer, often referred to as ductal carcinoma in situ (DCIS), and help early-stage invasive breast cancer patients with estrogen receptor-positive (ER+) disease evaluate if they will benefit from chemotherapy.

Please take the quick quiz below to help you determine whether the Oncotype DX test may be appropriate for you:

Are you a newly diagnosed breast cancer patient or caregiver trying to determine what treatment plan is right for you or a loved one?